# A Study of RO4989991 in Patients With Allergic Rhinitis

> **NCT01152619** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 24 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Placebo
- **DRUG:** RO4989991

## Key facts

- **NCT ID:** NCT01152619
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2016-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01152619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01152619, "A Study of RO4989991 in Patients With Allergic Rhinitis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01152619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*